Market Cap
US$1.6b
Last Updated
2020/10/21 00:39 UTC
Data Sources
Company Financials
Executive Summary
CorVel Corporation provides workers’ compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. More Details
Snowflake Analysis
Flawless balance sheet with acceptable track record.
Similar Companies
Share Price & News
How has CorVel's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CRVL has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
3.4%
CRVL
-1.1%
US Healthcare
-2.4%
US Market
1 Year Return
19.8%
CRVL
18.6%
US Healthcare
18.2%
US Market
Return vs Industry: CRVL underperformed the US Healthcare industry which returned 22.1% over the past year.
Return vs Market: CRVL underperformed the US Market which returned 19.5% over the past year.
Shareholder returns
| CRVL | Industry | Market | |
|---|---|---|---|
| 7 Day | 3.4% | -1.1% | -2.4% |
| 30 Day | 4.8% | 5.0% | 4.2% |
| 90 Day | 17.8% | 2.9% | 6.3% |
| 1 Year | 19.8%19.8% | 20.2%18.6% | 20.9%18.2% |
| 3 Year | 53.8%53.8% | 31.7%26.1% | 41.2%31.8% |
| 5 Year | 171.9%171.9% | 59.2%47.7% | 84.8%63.9% |
Price Volatility Vs. Market
How volatile is CorVel's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Are Robust Financials Driving The Recent Rally In CorVel Corporation's (NASDAQ:CRVL) Stock?4 weeks ago | Simply Wall St
Investors Who Bought CorVel (NASDAQ:CRVL) Shares Five Years Ago Are Now Up 165%1 month ago | Simply Wall St
CorVel Corporation (NASDAQ:CRVL) Not Flying Under The RadarValuation
Is CorVel undervalued compared to its fair value and its price relative to the market?
39.45x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CRVL ($90.73) is trading above our estimate of fair value ($33.66)
Significantly Below Fair Value: CRVL is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CRVL is poor value based on its PE Ratio (39x) compared to the US Healthcare industry average (23.6x).
PE vs Market: CRVL is poor value based on its PE Ratio (39x) compared to the US market (19x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CRVL's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CRVL is overvalued based on its PB Ratio (8.2x) compared to the US Healthcare industry average (3.1x).
Next Steps
Future Growth
How is CorVel forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
13.7%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CorVel has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine CorVel's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Explore growth companies in the Healthcare industry.
Past Performance
How has CorVel performed over the past 5 years?
13.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CRVL has high quality earnings.
Growing Profit Margin: CRVL's current net profit margins (7.4%) are lower than last year (8.1%).
Past Earnings Growth Analysis
Earnings Trend: CRVL's earnings have grown by 13.7% per year over the past 5 years.
Accelerating Growth: CRVL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CRVL had negative earnings growth (-12.5%) over the past year, making it difficult to compare to the Healthcare industry average (28%).
Return on Equity
High ROE: CRVL's Return on Equity (21.3%) is considered high.
Next Steps
Financial Health
How is CorVel's financial position?
Financial Position Analysis
Short Term Liabilities: CRVL's short term assets ($224.4M) exceed its short term liabilities ($138.5M).
Long Term Liabilities: CRVL's short term assets ($224.4M) exceed its long term liabilities ($88.4M).
Debt to Equity History and Analysis
Debt Level: CRVL is debt free.
Reducing Debt: CRVL has not had any debt for past 5 years.
Debt Coverage: CRVL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CRVL has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is CorVel current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CRVL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CRVL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CRVL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CRVL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CRVL's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
4.2yrs
Average management tenure
CEO
Michael Combs (56 yo)
1.75yrs
Tenure
US$1,432,053
Compensation
Mr. Michael G. Combs has been as the President of CorVel Corporation since April 1, 2017 and has been its Chief Executive Officer since January 18, 2019. Mr. Combs Chief Information Officer at CorVel Corp ...
CEO Compensation Analysis
Compensation vs Market: Michael's total compensation ($USD1.43M) is below average for companies of similar size in the US market ($USD4.44M).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & COO | 29.5yrs | US$401.71k | 8.9% $ 146.4m | |
| President & CEO | 1.75yrs | US$1.43m | 0.021% $ 348.7k | |
| Chief Financial Officer | 2yrs | US$512.62k | 0.0071% $ 117.1k | |
| Vice President of Accounting | 6.33yrs | US$275.14k | 0.0011% $ 18.7k | |
| Chief Information Officer | 3.5yrs | US$596.59k | 0% $ 0 | |
| Chief Marketing Officer | 3.92yrs | US$625.10k | 0.028% $ 467.4k | |
| Investor Relation | no data | no data | no data | |
| Vice President of Legal & Human Resources | 4.5yrs | no data | no data | |
| Secretary | 25.33yrs | US$223.00k | no data |
4.2yrs
Average Tenure
56yo
Average Age
Experienced Management: CRVL's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & COO | 29.5yrs | US$401.71k | 8.9% $ 146.4m | |
| Independent Director | 29.42yrs | US$91.70k | 0.74% $ 12.2m | |
| Independent Director | 30.08yrs | US$87.70k | 1.15% $ 18.8m | |
| Lead Independent Director | no data | US$99.70k | 0.35% $ 5.7m | |
| Independent Director | 17.42yrs | US$91.70k | 0.28% $ 4.6m | |
| Independent Director | 12.67yrs | US$88.70k | 0.067% $ 1.1m |
29.4yrs
Average Tenure
72yo
Average Age
Experienced Board: CRVL's board of directors are seasoned and experienced ( 29.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CRVL insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
CorVel Corporation's company bio, employee growth, exchange listings and data sources
Key Information
- Name: CorVel Corporation
- Ticker: CRVL
- Exchange: NasdaqGS
- Founded: 1987
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$1.644b
- Shares outstanding: 17.93m
- Website: https://www.corvel.com
Number of Employees
Location
- CorVel Corporation
- 1920 Main Street
- Suite 900
- Irvine
- California
- 92614
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CRVL | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jun 1991 |
Biography
CorVel Corporation provides workers’ compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. I ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/10/21 00:39 |
| End of Day Share Price | 2020/10/20 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2020/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.